Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Grand Pharmaceutical Group Limited ( (HK:0512) ) has issued an update.
Grand Pharmaceutical Group Limited announced a Business Collaboration Agreement between its subsidiary Chengdu Shetai and Sirtex Medical US. This agreement allows both parties to engage each other for services related to research and development of medical device and radiopharmaceutical products, with a financial cap of US$1.2 million annually. The collaboration is expected to enhance the company’s capabilities in clinical development and logistics support, potentially strengthening its position in the medical industry.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited is a company involved in the medical industry, focusing on the research and development of medical device products and radiopharmaceutical products. The company collaborates with various partners to enhance its offerings in treatment methods for human diseases.
YTD Price Performance: 29.63%
Average Trading Volume: 9,231,823
Technical Sentiment Signal: Sell
Current Market Cap: HK$21.12B
See more data about 0512 stock on TipRanks’ Stock Analysis page.